PRIGX
Price
$24.42
Change
+$0.22 (+0.91%)
Updated
Jun 18 closing price
Net Assets
300.36M
TEDIX
Price
$31.04
Change
-$0.02 (-0.06%)
Updated
Jun 18 closing price
Net Assets
8.99B
Interact to see
Advertisement

PRIGX vs TEDIX

PRIGX vs TEDIX Comparison Chart in %
View a ticker or compare two or three
VS
PRIGX vs. TEDIX commentary
Jun 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRIGX is a Hold and TEDIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TEDIX has more cash in the bank: 8.99B vs. PRIGX (300M). PRIGX pays higher dividends than TEDIX: PRIGX (1.91) vs TEDIX (1.61). PRIGX was incepted earlier than TEDIX: PRIGX (14 years) vs TEDIX (33 years). TEDIX (1.20) is less costly to investors than PRIGX (0.89). PRIGX is a more actively managed with annual turnover of: 76.90 vs. TEDIX (42.28). TEDIX has a lower initial minimum investment than PRIGX: TEDIX (1000) vs PRIGX (500000). PRIGX annual gain was more profitable for investors over the last year : 35.95 vs. TEDIX (2.53). PRIGX return over 5 years is better than : 66.09 vs. TEDIX (4.11).
PRIGXTEDIXPRIGX / TEDIX
Total Expense Ratio0.681.2057%
Annual Report Gross Expense Ratio0.891.2074%
Fund Existence14 years33 years-
Gain YTD17.9710.3884,630%
Front LoadN/A6%-
Min. Initial Investment500000100050,000%
Min. Initial Investment IRAN/AN/A-
Net Assets300M8.99B3%
Annual Yield % from dividends1.911.61119%
Returns for 1 year35.952.531,420%
Returns for 3 years63.418.33761%
Returns for 5 years66.094.111,610%
Returns for 10 years150.0517.99834%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBMIX62.081.70
+2.82%
Neuberger Small Cap Growth Inv
HGOVX90.201.99
+2.26%
Hartford Growth Opportunities R6
RYDCX131.752.09
+1.61%
Rydex Mid-Cap 1.5x Strategy C
HMCNX17.970.12
+0.67%
Harbor Mid Cap Investor
FBTAX39.900.01
+0.03%
Fidelity Advisor Biotechnology A